Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2012 Childhood lupus in India: study of 74 children from a single tertiary care centre. 10th Asia-Pacific League of Associations for Rheumatology Congress, Bangkok, Thailand Abstracts 10th APLAR; abstract number 164; page 83
2. 2012 Pregnancy outcome in Systemic Lupus Erythematosus. 10th Asia-Pacific League of Associations for Rheumatology Congress, Bangkok, Thailand Abstracts 10th APLAR; abstract number 113; page 57.
3. 2012 Psoriatic Arthritis In Fitzpatrick’s Dermatology in General Medicine 8th edition
4. 2011 1IL13 Gene Polymorphism is a marker for psoriatic arthritis among psoriasis patients. Ann Rheum Dis ;70:1594-8.
5. 2011 The association between environmental factors and onset of psoriatic arthritis in patients with psoriasis Arthritis Care Res (Hoboken);63:1091-7.
6. 2011 Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens ;77:554-61
7. 2011 Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods J Rheumatol ;38:1066-70.
8. 2011 Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50: A Reliable Index for Measuring Improvement in Disease Activity J Rheumatol Published online Feb 15 2011. PubMed PMID: 21324961.
9. 2011 The incidence of arthritis in a prospective cohort of psoriasis patients Arthritis Care Res (Hoboken) ;63:619-22.
10. 2011 Inflammation in an individual joint predicts damage to that joint in Psoriatic Arthritis Ann Rheum Dis ;70:305-308.
11. 2011 Sensitivity to change of radiographic scoring instruments in axial psoriatic arthritis. Ann Rheum Dis ;70(Suppl3):239
12. 2011 The Functional MICA-129 Polymorphism is Associated with Psoriatic Disease Independently of HLA-B and C J Rheumatol ;38(6):1134
13. 2011 Psoriatic arthritis (PsA) in Canadian Clinical Practice: the PsA Assessment in Rheumatology (PAIR). J Rheumatol ;38(6):1162
14. 2011 Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension J Rheumatol ;38(6):1168
15. 2011 SLEDAI-2K Responder Index (SRI)-50: A reliable index for measuring improvement in disease activity. Lupus ;20(4):383
16. 2011 Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford)
17. 2011 Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program Rheumatology (Oxford);50:25-31
18. 2011 Expression patterns of natural killer receptor genes in inflamed joints and peripheral blood of patients with psoriatic arthritis. Tissue Antigens 2011 Aug 25. doi: 10.1111/j.1399-0039.2011.01764.x.
19. 2011 Patient reported outcome in psoriatic arthritis: a comparison of web based versus paper completed questionnaires. J Rheumatol ;38:2619-24.
20. 2011 Review of Clinical Registries of Psoriatic Arthritis: Lessons Learned? Value for the Future? Curr Rheumatol Rep ;13:346-352.
21. 2011 Standardizing the monitoring of outcome measures: imaging in psoriatic arthritis. Int J Clin Rheumatol ;6:77-86.
22. 2011 Cardiovascular Comorbidities in Psoriasis and Psoriatic Arthritis: Pathogenesis, Consequences for Patient Management, and Future Research Agenda: A Report from the GRAPPA 2009 Annual Meeting. J Rheumatol ;38:567-71
23. 2011 TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis J Invest Dermatol. Nov 24. doi: 10.1038/jid.2011.376.
24. 2011 Toronto Psoriatic Arthritis Screening (ToPAS) Questionnaire: A Report from the GRAPPA 2009 Annual Meeting J Rheumatol ;38:546-7.
25. 2011 Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes Arthritis Care Res (Hoboken) ;63: 1440-1447.
26. 2011 Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis. 2011 Sep 12. [Epub ahead of print] PubMed PMID: 21914627.
27. 2011 The association between smoking and development of psoriatic arthritis among psoriasis patients Ann Rheum Dis. 2011 Sep 27. [Epub ahead of print] PMID: 21953342.
28. 2011 Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis Ann Rheum Dis. 2011 Sep 6. [Epub ahead of print] PubMed PMID: 21900282.
29. 2011 Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis Arthritis Care Res (Hoboken) ;63:1729-1735.
30. 2010 MICA Alleles Differentiate Skin and Joint Manifestations in Psoriatic Disease J Rheumatol ;37:1305
31. 2010 Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun ;34:J314-21
32. 2010 Genetics of Psoriasis and Psoriatic Arthritis Indian J Dermatol ;55:151-56.
33. 2010 HLA Bw4 alleles and HLA C alleles that have high cell-surface expression are associated with susceptibility to Psoriatic Arthritis (PsA). Arthritis Rheum ;62(supplement) S826
34. 2010 The Genetic Basis of Spondyloarthritis: SPARTAN/IGAS 2009 J Rheumatol ;37:2626-2631
35. 2010 Current Controversies in Spondyloarthritis: SPARTAN J Rheumatol ;37:2617-2623
36. 2010 Genetics of Ankylosing Spondylitis and Psoriatic Arthritis. Best Pract Res Clin Rheumatol ;24:579-88
37. 2010 Update on Biomarkers in Psoriatic Arthritis Curr Rheumatol Rep ;12:288-94.
38. 2010 Association between Killer-cell Immunoglobulin-like Receptor (KIR) gene polymorphisms and Psoriatic Arthritis (PsA). Arthritis Rheum ;62(supplement) S823
39. 2010 Peripheral blood gene expression profiling differentiates psoriatic arthritis from psoriasis without arthritis Ann Rheum Dis ;69(Suppl3):157
40. 2010 Prevalence of Vitamin D Insufficiency and Clinical Outcomes in Psoriatic Arthritis Patients J Rheumatol ;37:1347
41. 2010 Macrophage Migration Inhibition Factor gene polymorphism is associated with relapse in joints that achieved remission after intra-articular steroid injection in psoriatic arthritis. J Rheumatol ;37:1327
42. 2010 Response to TNF - α blockers in Psoriatic arthritis – an observational cohort study. J Rheumatol ;37:1285
43. 2010 Reliability of radiographic scoring methods in Axial Psoriatic Arthritis (AxPsA). J Rheumatol ;37:1320
44. 2010 Soluble Biomarkers Predict Response to Anti-Tumour Necrosis Factor (TNF) Therapy in Psoriatic Arthritis (PsA). J Rheumatol ;37:1282
45. 2010 Smoking is negatively associated with development of psoriatic arthritis among psoriasis patients. Arthritis Rheum ;62(supplement) S818
46. 2010 The association of IL-13 polymorphism with psoriatic arthritis among psoriasis patients Arthritis Rheum ;62(supplement) S830
47. 2010 Seasonal Variation in Vitamin D Levels in Patients with Psoriatic Arthritis from Northern and Southern Latitudes and its Association with Clinical Outcomes. Arthritis Rheum ;62(supplement) S327
48. 2010 Dactylitis in Psoriatic Arthritis (PsA): Prevalence and Response to Therapy in the Biologic Era. Arthritis Rheum ;62(supplement) S808
49. 2010 HLA- B*27 and Cw*06 are risk alleles for psoriatic arthritis among psoriasis patients Arthritis Rheum ;62(supplement) S826
50. 2010 HLA-Cw*06 allele increases the duration of time between the onset of psoriasis and psoriatic arthritis Arthritis Rheum ;62(supplement) S220
51. 2010 Environmental risk factors for psoriatic arthritis among patients with psoriasis – A case-control study Arthritis Rheum ;62(supplement) S809
52. 2010 Comparison of Comorbid Disease Burden in Psoriasis and Psoriatic Arthritis (PsA). Arthritis Rheum ;62(supplement) S806
53. 2010 DC-STAMP (Dendritic Cell-Specific Transmembrane protein), a potential biomarker to predict the risk of psoriasis patients in developing psoriatic arthritis Arthritis Rheum ;62(supplement) S217.
54. 2010 Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Arthritis Rheum ;62(supplement) S956
55. 2010 Reliability of radiographic scoring methods in Axial Psoriatic Arthritis. Arthritis Rheum ;62(supplement) S817
56. 2010 Inflammation in an individual joint predicts damage to that joint in Psoriatic Arthritis Arthritis Rheum ;62(supplement) S223
57. 2010 MICA*016 Allele Differentiates Skin and Joint Manifestations of Psoriatic Disease Arthritis Rheum ;62(supplement) S828.
58. 2010 Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res (Hoboken) ;62:970-6.
59. 2010 Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis J Rheumatol ;37: 809-815.
60. 2010 Time and predictors of response to tumour necrosis factor-{alpha} blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort Rheumatology (Oxford) ;49:1361-66.
61. 2010 Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford) ;49:1367-73.
62. 2010 Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis Rheumatology (Oxford) ;49:1399-1405.
63. 2010 Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in Psoriatic Arthritis. J Rheumatol ;37:1508-1512
64. 2010 Is ASDAS better than BASDAI as a measure of disease activity in Axial Psoriatic Arthritis? Ann Rheum Dis ;69:2160-2164.
65. 2009 Frequency and predictors of minimal disease activity in an observational PsA cohort Ann Rheum Dis ;68(Suppl3):137
66. 2009 Achieving minimal disease activity (MDA) criteria decreases progression of joint damage in PsA Ann Rheum Dis ;68(Suppl3):659
67. 2009 Spondylitis in Patients with Psoriatic Arthritis (PsA). 2nd World Psoriasis and Psoriatic Arthritis conference, Stockholm,
68. 2009 Soluble Biomarkers Predict Response to Anti-Tumour Necrosis Factor (TNF) Therapy in Psoriatic Arthritis Arthritis Rheum ;60:S666
69. 2009 Soluble biomarkers in psoriatic disease: differences between psoriasis and psoriatic arthritis Arthritis Rheum ;60:S666
70. 2009 Microarray analyses of peripheral blood cells identifies gene expression profile that differentiates psoriatic arthritis (PsA) from psoriasis and controls Arthritis Rheum ;60:S537
71. 2009 Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in Psoriatic Arthritis Arthritis Rheum ;60:S194
72. 2009 Comparison Between Inspire and Domjan Method for Measuring Lumbar Lateral Flexion in Patients of Psoriatic Arthritis (PsA) and Correlation with Radiographic Damage. Arthritis Rheum ;60:S203
73. 2009 Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis ;68:497–501.
74. 2009 Familial aggregation of Psoriatic Arthritis. Ann Rheum Dis ;68: 664-7.
75. 2009 International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis Arthritis Rheum ;61:1235-1242.
76. 2009 Axial psoriatic arthritis: Update on a longterm prospective study. J Rheumatol ;36:2744-50
77. 2009 Activating KIRs in Siblings of Patients with Psoriatic Arthritis. Hum Immunol ;70:S88
78. 2009 Killer Cell Immunoglobulin-Like Receptor Gene Expression in Inflamed Joints of Patients with Psoriatic Arthritis (PsA). Hum Immunol ;70:S133
79. 2009 Epidemiology of Psoriatic Arthritis J Rheumatol ;36:213-215
80. 2009 From Ankylosis to Pencil-in-Cup Deformity in Psoriatic Arthritis- A Case Report. Clinical and Experimental Rheumatology 2009 Clin Exp Rheumatol ;27:661-3.
81. 2009 Achieving minimal disease activity (MDA) criteria decreases progression of joint damage in psoriatic arthritis Rheumatology (Oxford) ;48:i51
82. 2009 Soluble Biomarkers Differentiate Psoriatic Arthritis from Psoriasis Ann Rheum Dis ;68(Suppl3):139
83. 2009 Frequency and Predictors of Minimal Disease Activity in an Observational PsA Cohort Rheumatology (Oxford) ; 48:i50
84. 2008 A Pilot Study on Biomarkers that Differentiate Psoriatic Arthritis from Psoriasis alone. Arthritis Rheum ;58:3997
85. 2008 Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Psoriatic Arthritis (PsA) Arthritis Rheum ;58(Suppl 9)S366.
86. 2008 Risk Factors for the Development of Spondylitis in Patients with Psoriatic Arthritis (PsA) Arthritis Rheum ;58(Suppl 9)S364
87. 2008 Progression of Spondylitis in Patients with Psoriatic Arthritis (PsA) Arthritis Rheum ;58(Suppl 9)S365
88. 2008 Defining Psoriatic Spondylitis (PsSp). Arthritis Rheum ;58(Suppl 9)S365
89. 2008 Clinical Predictors for Psoriatic Arthritis (PsA) in Patients with Psoriasis. Arthritis Rheum ;58(Suppl 9)S364
90. 2008 A Pharmacogenetic Study on the efficacy of Methotrexate (MTX) In Psoriatic Arthritis (PsA). Arthritis Rheum ;58(Suppl 9)S364
91. 2008 Killer-cell Immunoglobulin-like Receptor (KIR) Haplotypes in Patients with Psoriatic Arthritis (PsA) and their Family Members Human Genome Variation Meeting 2008, Toronto, Canada
92. 2008 . Probands underestimate the prevalence of psoriatic arthritis in their relatives J Rheumatol ;35:1209
93. 2008 Reappraisal of the Effectiveness of Methotrexate in Psoriatic Arthritis: Results from a Longitudinal Observational Cohort. J Rheumatol ;35:469-71
94. 2008 Soluble Endothelial cell adhesion molecules and their relationship with disease activity in Takayasu’s Arteritis. J Rheumatol;35:1842-5.
95. 2008 Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus Lupus ;17:793-8
96. 2008 Early Psoriatic Arthritis: Establishing a cohort of patients with Psoriasis uncomplicated by Arthritis J Rheumatol ;35:1172
97. 2008 Predictors of Response to Intra-articular Steroid Injection in Psoriatic Arthritis. Arthritis Rheum ;58:3991
98. 2008 Frequency and Predictors of Minimal Disease Activity in an Observational Psoriatic Arthritis Cohort Arthritis Rheum ;58:3997
99. 2008 Clinical predictors for psoriatic arthritis in patients with psoriasis. Br J Dermatol ;159:1394
100. 2008 A pharmacogenetic study on the efficacy of methotrexate in psoriatic arthritis. Br J Dermatol ;159:1410.
101. 2008 Genetics of Psoriasis and Psoriatic Arthritis: Update and Future Direction J Rheumatol ;35:1449-53.
102. 2008 Psoriatic Arthritis- the facts Oxford University Press, London . ISBN 978-0-19-923122-5
103. 2008 Sensitivity and Specificity of the CASPAR Criteria for Psoriatic Arthritis in a Family Medicine Clinic Setting J Rheumatol ;35:2069-70.
104. 2007 Familial aggregation of Psoriatic Arthritis (PsA): preliminary analysis of 100 consecutive families of patients with PsA. Ann Rheum Dis ;66(Suppl II):415
105. 2007 Unusual KIR Haplotypes in Patients with Psoriatic Arthritis and their Family Members Hum Immunol ;68(Suppl 1)S57.
106. 2007 KIR Haplotypes in Psoriatic Arthritis Families Hum Immunol ;68(Suppl 1)S61
107. 2007 The INSPIRE Study Group. Composite Indices for Disease Activity in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Arthritis Rheum ;56(Suppl 9)S481
108. 2007 Clinical and Radiographic Differences between Primary Ankylosing Spondylitis, Psoriatic Spondylitis and Spondylitis associated with Inflammatory Bowel Disease. Arthritis Rheum ;56(Suppl 9)S259
109. 2007 Development and Validation of a Screening Questionnaire for Psoriatic Arthritis (PsA). Arthritis Rheum ;56(Suppl 9)S798
110. 2007 Radiographic Spinal Damage and Spinal Mobility Correlate Poorly In Psoriatic Spondylitis (Ps-Sp). Arthritis Rheum ;56(Suppl 9)S483.
111. 2007 Recurrence Risk of Psoriatic Arthritis (PsA) and Psoriasis (Ps) in Relatives of Patients with PsA. Arthritis Rheum ;56(Suppl 9)S797.
112. 2007 International Multi-centre Psoriasis and Psoriatic Arthritis Reliability Trial (GRAPPA-IMPART): Assessment of Skin, Joints, Nails and Dactylitis Arthritis Rheum ;56(Suppl 9)S798.
113. 2007 CASPAR criteria are sensitive in early Psoriatic Arthritis (PsA) and are accurate when applied to patients attending a family practice clinic. Ann Rheum Dis ;66(Suppl II):415
114. 2007 INSPIRE Study Group. Evaluating Patient Self-Reported Instruments in Spondyloarthritis: results from the INternational SPondyloarthritis Inter-observer Reliability Exercise – the INSPIRE Study. J Rheumatol ;34:1608
115. 2007 Does axial disease exhibit a different phenotype in Primary Ankylosing Spondylitis versus Psoriatic Spondylitis? J Rheumatol ;34:1608
116. 2007 Association of Killer cell Immunoglobulin-like Receptors (KIRs) with vascular events and autoantibodies in SLE. J Rheumatol ;34:1610
117. 2007 Metabolic syndrome in SLE: increased prevalence and associations with disease manifestations J Rheumatol ;34:1609.
118. 2007 Relationship between spinal mobility and radiographic damage in Ankylosing Spondylitis (AS) and Psoriatic Spondylitis (PSp). J Rheumatol ;34:1596
119. 2007 CASPAR criteria are sensitive in early Psoriatic Arthritis (PsA) and are accurate when applied to patients attending a family practice clinic. J Rheumatol ;34:1620
120. 2007 Familial aggregation of Psoriatic Arthritis (PsA): preliminary analysis of 100 consecutive families of patients with PsA. J Rheumatol ;34:1596
121. 2007 Familial aggregation of Psoriatic Arthritis Second Canadian Genetic Epidemiology and Statistical Genetics meeting, Toronto 15-17 April 2007. Abstract book page number 9
122. 2007 Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis. Scand J Rheumatol ;36:409
123. 2007 Relationship between Spinal Mobility and Radiographic Damage in Ankylosing Spondylitis and Psoriatic Spondylitis: A Comparative Analysis J Rheumatol ;34:2463-5.
124. 2007 Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum ;57:1560-1563.
125. 2007 International SPondyloarthritis Inter-observer Reliability Exercise – the INSPIRE study: II. Assessment of peripheral joints, enthesitis and dactylitis. J Rheumatol ;34:1740-5.
126. 2007 International SPondyloarthritis Inter-observer Reliability Exercise – the INSPIRE study: I. Assessment of Spinal measures. J Rheumatol ;34:1733-9
127. 2007 Functional Assessment of Chronic Illness Therapy (FACIT)- Fatigue Scale is valid in patients with Psoriatic Arthritis (PsA). Ann Rheum Dis ;66:936-9
128. 2006 Validation of the FACIT-fatigue in psoriatic arthritis (PsA). J Rheumatol ;33:387.
129. 2006 Effectiveness of methotrexate in psoriatic arthritis: reappraisal of a clinic’s experience Ann Rheum Dis ;65(Suppl II):638.
130. 2006 INSPIRE lateral flexion: a new method to measure lateral spinal mobility in patients with spondyloarthritis (SpA). Ann Rheum Dis ;65(Suppl II):208
131. 2006 Functional assessment of chronic illness therapy fatigue scale in psoriatic arthritis - a validation study Ann Rheum Dis ;65(Suppl II):210
132. 2006 International spondyloarthritis inter-observer reliability exercise – the INSPIRE study. Ann Rheum Dis ;65(Suppl II):217.
133. 2006 INSPIRE study group. Structure-Function relationship in the spine: a systematic analysis in Ankylosing Spondylitis and Psoriatic Arthritis Arthritis Rheum;54(Suppl 9)S717
134. 2006 Evaluating Enthesitis in Patients With Spondyloarthritis (SpA). Arthritis Rheum ;54(Suppl 9)S724.
135. 2006 INSPIRE Lateral Flexion: A New Method to Measure Lateral Spinal Mobility in Patients With Spondyloarthritis Arthritis Rheum ;54(Suppl 9)S476
136. 2006 Association of Killer cell immunoglobulin-like receptors (KIR) with vascular events and autoantibodies in SLE Arthritis Rheum ;54(Suppl 9)S294
137. 2006 Metabolic syndrome in SLE: Increase prevalence and associations with disease manifestations. Arthritis Rheum ;54(Suppl 9)S434
138. 2006 CASPAR criteria are sensitive in early Psoriatic Arthritis. Arthritis Rheum ;54(Suppl 9)S794.
139. 2006 Lack of clinical association with antibodies to ribosomal P proteins in Indian patients with Systemic Lupus Erythematosus. J Rheumatol ;33:1987-9.
140. 2006 Are the CASPAR Criteria for Psoriatic Arthritis accurate when applied to patients attending a family practice clinic? Arthritis Rheum :54:4091
141. 2006 Does axial disease exhibit a different phenotype in Primary Ankylosing Spondylitis versus Psoriatic Spondylitis? Arthritis Rheum :54:4091
142. 2006 INSPIRE Hip Mobility: A New method to Measure Hip Mobility in Patients with Rheumatic Diseases Arthritis Rheum ;54(Suppl 9)S473
143. 2006 INternational SPondyloarthritis Inter-Observer Reliability Exercise - The INSPIRE Study Arthritis Rheum ;54(Suppl 9)S724
144. 2005 How I would treat Psoriatic Arthritis Acta Reum Port ;30:203-12
145. 2005 Mixed Connective Tissue Disease: not a rare entity in India. Annual conference of Association of Physicians of India, Mumbai, India. Journal of Associations of Physicians of India ;53:268.
146. 2005 Screening depression in persons with seronegative and seropositive Rheumatoid arthritis 42nd National Conference of All India Occupational Therapists Association, Hyderabad, India
147. 2005 A Reappraisal of the Effectiveness of Methotrexate (MTX) in Psoriatic Arthritis (PsA): A Clinic Experience Arthritis Rheum ;52(Suppl 9):S638
148. 2005 Role of soluble cell adhesion molecules in assessing disease activity in Takayasu’s Arteritis J Am Coll Cardiol ;45(3 suppl A):380A.
149. 2005 Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT-Fatigue) in patients with psoriatic arthritis (PsA). Arthritis Rheum ;52:4084
150. 2005 Pulmonary Hypertension not a major feature of early mixed connective tissue disorder: a prospective clinicoserological study J Postgrad Med. ;51:104-8
151. 2005 Active disease during pregnancy is associated with poor foetal outcome in Indian patients with systemic lupus erythematosus. Rheumatol Int ;26:152-6.
152. 2004 Clinical profile of psoriatic arthritis. Annual conference of the Karnataka chapter of the Association of Physicians of India, Shimoga, Karnataka, India
153. 2004 Clinical Profile of mixed connective tissue disease in patients from southern India. Annual conference of the Karnataka chapter of the Association of Physicians of India, Shimoga, Karnataka, India
154. 2003 Effect of Lead exposure on the immune response of some occupationally exposed individuals Toxicology ;188:251-259
155. 2003 effect of Lead exposure on the immune system. Indo-US colloquium on molecular targets of xenobiotic exposure: role in susceptibility to diseases, Industrial Toxicology Research Centre, Lucknow, India
156. 2003 Alopecia totalis in systemic lupus Erythematosus. Journal of Indian Rheumatology Association ;11:22
157. 2003 Antibodies to ribosomal P proteins in Indian patients with systemic lupus Erythematosus. XXXth Annual conference of Indian Immunology Society, Lucknow, India
158. 2002 Effect of Lead exposure on cytokine production and cell surface marker expression. . XXIXth Annual conference of Indian Immunology Society, Bhubhaneshwar, India
159. 2002 Adult-onset Still’s disease. Journal of Indian Rheumatology Association ;10:19-21.
160. 2002 HIV Vaccine: current status. JK Science ;4:110-114
161. 2002 Effect of Lead on T lymphocyte proliferation and NK cell cytotoxicity in occupationally exposed individuals . XXIXth Annual conference of Indian Immunology Society, Bhubhaneshwar, India
162. 2002 Childhood lupus in India: study of 74 children from a single tertiary care centre. Annual conference of the Indian Rheumatology Association, Bangalore, India. Journal of Indian Rheumatology Association ;10:S10.
163. 2002 Prevalence and clinical association of antiribosomal P antibodies in systemic lupus Erythematosus. Annual conference of the Indian Rheumatology Association, Bangalore, India Journal of Indian Rheumatology Association ;10:S3-4.
164. 2001 Pregnancy outcome in systemic lupus Erythematosus. Annual conference of the Indian Rheumatology Association, Chandigarh, India. Journal of Indian Rheumatology Association ;9:S13
165. 2001 peripheral symmetric gangrene: a diagnostic dilemma. Annual conference of the Indian Rheumatology Association, Chandigarh, India. Journal of Indian Rheumatology Association;9:S13
166. 2001 Lacrimal gland enlargement as manifestation of limited relapse of Wegener’s granulomatosis Journal of Indian Rheumatology Association ;9:15.
167. 2000 Acute Myoedema: an unusual presenting manifestation of hypothyroid myopathy. Postgrad Med J. ;76:99-100.
168. 2000 Impact of Lead exposure on pituitary-thyroid axis in humans Biometals ;13:187-92
169. 1999 Blood Lead levels and its effect on health of occupationally exposed individuals. MD Thesis. Postgraduate Institute of Medical Education and Research


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.